![]() | UK data show that one in 13 men and one in 23 women will develop lung cancer. |
The largest number of new cases is seen in countries of the Russian Federation, as there is a high proportion of smokers.
The average cost of treating a patient with SCLC has been estimated as €17,000 (2001).
Hospitalisation accounts for almost 50% of the costs of care and chemotherapy for 13%.
Chemotherapy can improve symptoms and quality of life. It has some effect on the length of survival but currently is rarely curative.
Consequently, assessment of the cost-effectiveness of this treatment is particularly important.